Akebia Therapeutics (AKBA) EPS (Basic) (2013 - 2026)
Akebia Therapeutics (AKBA) posted quarterly EPS (Basic) of -$0.03 for Q1 2026, down 230.63% year-over-year from $0.03 in Q1 2025, and up 28.79% quarter-over-quarter from -$0.05 in Q4 2025.
Akebia Therapeutics (AKBA) EPS (Basic) (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported EPS (Basic) for 14 consecutive years, with -$0.03 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 230.63% year-over-year to -$0.03; the TTM figure through Mar 2026 stood at -$0.08 (up 60.08% YoY), while the FY2025 annual figure was -$0.02, up 93.68% from the prior year.
- EPS (Basic) improved to -$0.03 in Q1 2026 per AKBA's latest filing, from -$0.05 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.16 in Q2 2022 and bottomed at -$0.35 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.07 across 5 years, with a median of -$0.05 in 2025.
- Annual changes were most pronounced in 2022 — EPS (Basic) surged 131.16% — and 2024, when it slumped 3400.59%.
- Akebia Therapeutics' EPS (Basic) stood at -$0.02 in 2022, then jumped by 114.52% to $0.0 in 2023, then plunged by 3400.59% to -$0.11 in 2024, then soared by 55.96% to -$0.05 in 2025, then grew by 28.79% to -$0.03 in 2026.
- Business Quant data shows AKBA's EPS (Basic) at -$0.03 in Q1 2026, -$0.05 in Q4 2025, and $0.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.85 Bn | 39.19 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.40 Bn | 29.73 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.42 Bn | 15.03 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Akebia Therapeutics | 249.01 Mn | 93.46 Mn | 38.70 Mn | -0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.03 |
| Mar 31, 2026 | -0.03 |
| Dec 31, 2025 | -0.05 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.10 |
| Jun 30, 2024 | -0.04 |
| Mar 31, 2024 | -0.09 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | -0.08 |
| Jun 30, 2023 | -0.06 |
| Mar 31, 2023 | -0.15 |
| Dec 31, 2022 | -0.02 |
| Sep 30, 2022 | -0.29 |
| Jun 30, 2022 | 0.16 |
| Mar 31, 2022 | -0.35 |
| Dec 31, 2021 | -0.41 |
| Sep 30, 2021 | -0.34 |